Spinal Cord Stimulation Market Report 2026

Spinal Cord Stimulation Market Overview

• Spinal Cord Stimulation market size has reached to $3.41 billion in 2025 • Expected to grow to $5.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.8% • Growth Driver: Surge In Geriatric Demographics Fuels Growth In The Spinal Cord Stimulation Market • Market Trend: Nevro Introduces HFX iQ Spinal Cord Stimulation System To Elevate Chronic Pain Management Through AI And Innovation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Spinal Cord Stimulation Market?

Spinal cord stimulation is a relatively new technique that can assist in managing chronic pain when the damage or cause cannot be healed. It delivers electrical pulses directly into the spinal cord to control pain. The main types of spinal cord stimulation products are rechargeable and non-rechargeable. Rechargeable refers to something capable of being recharged with electricity. Rechargeable spinal cord stimulation is used to treat persistent neuropathic pain following unsuccessful back surgery. It is used for several applications, including failed back surgery syndrome (FBSS), degenerative disc disease (DDD), complex regional pain syndrome (CRPS), arachnoiditis, and others, and these are employed by various end users, such as hospitals, ambulatory surgery centers, and specialty clinics.

What Is The Spinal Cord Stimulation Market Growth Forecast?

The spinal cord stimulation market size is expected to see strong growth in the next few years. It will grow to $5.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to ai-enabled stimulation optimization, expansion of indications beyond pain, technological miniaturization, rising geriatric population, long-term pain therapy adoption. Major trends in the forecast period include closed-loop stimulation systems, rechargeable implantable devices, personalized neuromodulation programming, outpatient implantation procedures, integration with digital pain monitoring.

Global Spinal Cord Stimulation Market Segmentation

1) By Product: Rechargeable, Non-rechargeable 2) By Application: Failed Back Surgery Syndrome (FBSS), Degenerative Disc Disease (DDD), Complex Regional Pain Syndrome (CRPS), Arachnoiditis, Other Disease Indications 3) By End User: Hospitals, Ambulatory Surgery Centers, Specialty Clinics Subsegments: 1) By Rechargeable: Implantable Pulse Generators (IPGs), Rechargeable Lead Systems 2) By Non-Rechargeable: Non-Rechargeable Implantable Pulse Generators (IPGs), Non-Rechargeable Lead Systems

What Is The Driver Of The Spinal Cord Stimulation Market?

The increasing geriatric population is expected to propel the growth of the spinal cord stimulation market. Individuals aged 65 or older, commonly known as the geriatric population, exhibit distinctive healthcare and social requirements associated with the aging process. The rising geriatric population presents a significant opportunity for the growth of the spinal cord stimulation market, as ailments and chronic pain become more prevalent, the demand for spinal cord stimulation solutions is likely to increase, thereby contributing to the expansion of the market. For instance, in October 2025, according to the World Health Organization, a US-based specialized health agency, globally, 1 in 6 people will be 60 or older by 2030, and there will be a double amount of individuals in this age group (2.1 billion) by 2050. Therefore, the increasing geriatric population is propelling the growth of the spinal cord stimulation industry.

Key Players In The Global Spinal Cord Stimulation Market

Major companies operating in the spinal cord stimulation market are Abbott Laboratories,Medtronic PLC,Boston Scientific Corp.,LivaNova PLC,Globus Medical Inc.,ZimVie Inc.,Avanos Medical Inc.,Nevro Corp.,Saluda Medical Pty. Ltd.,Neuros Medical Inc.,Cirtec Medical Corp.,Mainstay Medical International plc,Gimer Medical,Stimwave Technologies,Vertiflex Inc.,SPR Therapeutics,Stimgenics Inc.,Axonics Modulation Technologies Inc.,Bioness Inc.,Nuvectra Corporation,Precision Spine Inc.,Vertiflex SCS Division

Global Spinal Cord Stimulation Market Trends and Insights

Major companies operating in the spinal cord stimulation market are focusing on developing innovative products, such as the Spinal Cord Stimulation System, to provide a significant advancement in spinal cord stimulation therapy. A spinal cord stimulation system is a medical device that involves the implantation of electrodes along the spinal cord to alleviate chronic pain. For instance, in March 2023, Nevro, a US-based medical device company that develops products for chronic pain treatment, launched the Revolutionary HFX iQ Spinal Cord Stimulation System, which is distinguished by its groundbreaking use of artificial intelligence, offering personalized pain relief through real-time adjustments based on extensive clinical data. With features such as the HFX algorithm and comprehensive pain management, the system not only represents a significant advancement in spinal cord stimulation therapy but also contributes to the market by providing innovative, data-backed, and AI-powered solutions for individuals with chronic pain.

What Are Latest Mergers And Acquisitions In The Spinal Cord Stimulation Market?

In November 2023, Nevro, a US-based medical device for chronic pain, acquired VYRSA Technologies for $40 million upfront and an additional $35 million in milestone payments amount. The acquisition is significant in the spinal cord stimulation market, as it diversifies Nevro's product offering, expands its portfolio and market reach, and addresses unmet medical needs in chronic pain treatment. VYRSA Technologies is a US-based medical technology company that focuses on sacroiliac joint fusion.

Regional Outlook

North America was the largest region in the spinal cord stimulation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Spinal Cord Stimulation Market?

The spinal cord stimulation market consists of sales of neurostimulators, leads, extensions, and handheld controllers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Spinal Cord Stimulation Market Report 2026?

The spinal cord stimulation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the spinal cord stimulation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.